Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Cornelius F Waller. (2012) Critical appraisal of biosimilar filgrastim (Nivestim™) for febrile and chemotherapy-induced neutropenia. Biosimilars 2, pages 1-11.
Read now
Read now
Articles from other publishers (68)
Chen Chen, Jian Qi & Juandong Wang. (2022) Anaphylaxis caused by pegylated recombinant human granulocyte colony-stimulating factor. Journal of Oncology Pharmacy Practice 29:3, pages 727-730.
Crossref
Crossref
Julia Skokowa, Birte Hernandez Alvarez, Murray Coles, Malte Ritter, Masoud Nasri, Jérémy Haaf, Narges Aghaallaei, Yun Xu, Perihan Mir, Ann-Christin Krahl, Katherine W. Rogers, Kateryna Maksymenko, Baubak Bajoghli, Karl Welte, Andrei N. Lupas, Patrick Müller & Mohammad ElGamacy. (2022) A topological refactoring design strategy yields highly stable granulopoietic proteins. Nature Communications 13:1.
Crossref
Crossref
Hee Won Cho, Ji Won Lee, Hee Young Ju, Ju Kyung Hyun, Keon Hee Yoo, Hong Hoe Koo, Kyunga Kim & Ki Woong Sung. (2022) Safety and Efficacy of Pegteograstim on Chemotherapy-induced Neutropenia in Children and Adolescents With Solid Tumors. Journal of Pediatric Hematology/Oncology 44:2, pages e362-e367.
Crossref
Crossref
Yoomin Jeon, Nora Lee, Seungjae Baek, JaeDuk Choi, Stanford Jhee & Howard Lee. (2022) A Randomized, Double-Blind, Placebo- and Active-Controlled, Escalating Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Subcutaneous Eflapegrastim in Healthy Japanese and Caucasian Subjects. Drugs in R&D 22:1, pages 71-87.
Crossref
Crossref
Fatemeh Yadavar Nikravesh, Samira Shirkhani, Elham Bayat, Yeganeh Talebkhan, Esmat Mirabzadeh, Masoumeh Sabzalinejad, Hooman Aghamirza Moghim Aliabadi, Leila Nematollahi, Yalda Hosseinzadeh Ardakani & Soroush Sardari. (2022) Extension of human GCSF serum half-life by the fusion of albumin binding domain. Scientific Reports 12:1.
Crossref
Crossref
Dongling Zou, Mingfang Guo & Qi Zhou. (2021) A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer. BMC Cancer 21:1.
Crossref
Crossref
Qiuji Wu, Qiu Li, Jun Zhang, Zhumei Luo, Jin Zhou, Jing Chen & Yong Luo. (2021) Comparison of Primary and Secondary Prophylaxis Using PEGylated Recombinant Human Granulocyte–Stimulating Factor as a Cost-Effective Measure in Malignant Neoplasms: A Multicenter Retrospective Study. Frontiers in Pharmacology 12.
Crossref
Crossref
Joo-Heung Kim, Nak-Hoon Son, Jun-Sang Lee, Ji-Eun Mun, Jee-Ye Kim, Hyung-Seok Park, Seho Park, Seung-Il Kim & Byeong-Woo Park. (2021) Time-Sequencing of the Neutrophil-to-Lymphocyte Ratio to Predict Prognosis of Triple-Negative Breast Cancer. Cancers 13:14, pages 3472.
Crossref
Crossref
Orkun İrsoy, Şanser Güz, Naz Beril Akan & Gönenç Yücel. (2021)
Dynamic
trade‐offs
in granulocyte
colony‐stimulating
factor (
G‐CSF
) administration during chemotherapy
. System Dynamics Review.
Crossref
Crossref
Birte Hernandez Alvarez, Julia Skokowa, Murray Coles, Perihan Mir, Masoud Nasri, Kateryna Maksymenko, Laura Weidmann, Katherine W. Rogers, Karl Welte, Andrei N. Lupas, Patrick Müller & Mohammad ElGamacy. (2020) Design of novel granulopoietic proteins by topological rescaffolding. PLOS Biology 18:12, pages e3000919.
Crossref
Crossref
John Harrold, Per Olsson Gisleskog, Isabelle Delor, Philippe Jacqmin, Juan Jose Perez-Ruixo, Adimoolam Narayanan, Sameer Doshi, Andrew Chow, Bing-Bing Yang & Murad Melhem. (2020) Quantification of Radiation Injury on Neutropenia and the Link between Absolute Neutrophil Count Time Course and Overall Survival in Nonhuman Primates Treated with G-CSF. Pharmaceutical Research 37:6.
Crossref
Crossref
Katerina Pilatova, Beatrix Bencsikova, Regina Demlova, Dalibor Valik & Lenka Zdrazilova-Dubska. (2018) Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment. Cancer Immunology, Immunotherapy 67:12, pages 1919-1929.
Crossref
Crossref
Sarfaraz K. NiaziSarfaraz K. Niazi. 2018. Biosimilars and Interchangeable Biologics. Biosimilars and Interchangeable Biologics
157
226
.
Weiwei Huang, Jian Liu, Yi Zeng, Fan Wu, Nani Li, Kan Chen, Yi Hong, LiLi Wang, Hongyu Zhen & Lin Lin. (2018) Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer. Cancer Chemotherapy and Pharmacology 82:4, pages 607-613.
Crossref
Crossref
Inderjeet Singh, Akash Patel, Ronak Patel & Vinu Jose. (2018) Pharmacokinetic and pharmacodynamic bioequivalence study of a pegfilgrastim biosimilar INTP5 in healthy subjects. Cancer Chemotherapy and Pharmacology 82:2, pages 329-337.
Crossref
Crossref
Sibylle Schirm, Christoph Engel, Sibylle Loibl, Markus Loeffler & Markus Scholz. (2017) Model-based optimization of G-CSF treatment during cytotoxic chemotherapy. Journal of Cancer Research and Clinical Oncology 144:2, pages 343-358.
Crossref
Crossref
John Lally, Steffi Malik, Eromona Whiskey, David M. Taylor, Fiona P. Gaughran, Amir Krivoy, Robert J. Flanagan, Aleksandar Mijovic & James H. MacCabe. (2017) Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor. Journal of Clinical Psychopharmacology 37:4, pages 441-446.
Crossref
Crossref
Christian Reichert, Remo Perozzo & Gerrit Borchard. (2016) Non-covalent modification of granulocyte-colony stimulating factor (G-CSF) by coiled-coil technology. International Journal of Pharmaceutics 511:1, pages 98-103.
Crossref
Crossref
Carlo Genova, Erika Rijavec & Francesco Grossi. (2016) Hematopoietic growth factors in lung cancer. Current Opinion in Oncology 28:2, pages 135-144.
Crossref
Crossref
Dieter H. Graessle, Harald Dörr, Alexander Bennett, Alla Shapiro, Ann M. Farese, Thomas J. MacVittie & Viktor Meineke. (2015) Comparing the Hematopoetic Syndrome Time Course in the NHP Animal Model to Radiation Accident Cases From the Database Search. Health Physics 109:5, pages 493-501.
Crossref
Crossref
Norberto C. Chavez-Tapia, Indira Mendiola-Pastrana, Victoria J. Ornelas-Arroyo, Camilo Noreña-Herrera, Desiree Vidaña-Perez, Guadalupe Delgado-Sanchez, Misael Uribe & Tonatiuh Barrientos-Gutierrez. (2015) Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysis. Annals of Hepatology 14:5, pages 631-641.
Crossref
Crossref
Tara Arvedson, James O’Kelly & Bing-Bing Yang. (2015) Design Rationale and Development Approach for Pegfilgrastim as a Long-Acting Granulocyte Colony-Stimulating Factor. BioDrugs 29:3, pages 185-198.
Crossref
Crossref
Sibylle Schirm, Christoph Engel, Markus Loeffler & Markus Scholz. (2014) A combined model of human erythropoiesis and granulopoiesis under growth factor and chemotherapy treatment. Theoretical Biology and Medical Modelling 11:1.
Crossref
Crossref
Angelica L. Quartino, Mats O. Karlsson, Henrik Lindman & Lena E. Friberg. (2014) Characterization of Endogenous G-CSF and the Inverse Correlation to Chemotherapy-Induced Neutropenia in Patients with Breast Cancer Using Population Modeling. Pharmaceutical Research 31:12, pages 3390-3403.
Crossref
Crossref
Kwang-Hee Shin, Kyoung Soo Lim, Howard Lee, In-Jin Jang & Kyung-Sang Yu. (2014) An assessment of the pharmacokinetics, pharmacodynamics, and tolerability of GCPGC, a novel pegylated granulocyte colony-stimulating factor (G-CSF), in healthy subjects. Investigational New Drugs 32:4, pages 636-643.
Crossref
Crossref
Michelle See, Vivianne Lee Chuen Shih, Han Kiat Ho, Tiffany Pooi Ling Tang, Mohamad Farid, Richard Hong Hui Quek, Miriam Tao, Soon Thye Lim & Alexandre Chan. (2014) A Pilot Study to Evaluate the Role of Therapeutic Drug Monitoring of Pegfilgrastim in Lymphoma Patients Receiving Chemotherapy. Proceedings of Singapore Healthcare 23:1, pages 13-20.
Crossref
Crossref
Li Young Ahn, Kwang-Hee Shin, Kyoung Soo Lim, Tae-Eun Kim, Hyewon Jeon, Seo Hyun Yoon, Joo-Youn Cho, Sang-Goo Shin, In-Jin Jang & Kyung-Sang Yu. (2013) Relationship Between Absolute Neutrophil Count Profiles and Pharmacokinetics of DA-3031, a Pegylated Granulocyte Colony-Stimulating Factor (Pegylated-G-CSF): A Dose Block-Randomized, Double-Blind, Dose-Escalation Study in Healthy Subjects. Clinical Drug Investigation 33:11, pages 817-824.
Crossref
Crossref
Kwang-Hee Shin, Tae-Eun Kim, Kyoung Soo Lim, Seo-Hyun Yoon, Joo-Youn Cho, Sei-Eun Kim, Kyung-Mi Park, Sang-Goo Shin, In-Jin Jang & Kyung-Sang Yu. (2013) Pharmacokinetic and Pharmacodynamic Properties of a New Long-Acting Granulocyte Colony-Stimulating Factor (HM10460A) in Healthy Volunteers. BioDrugs 27:2, pages 149-158.
Crossref
Crossref
Markus Scholz, Sibylle Schirm, Marcus Wetzler, Christoph Engel & Markus Loeffler. (2012) Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans. Theoretical Biology and Medical Modelling 9:1.
Crossref
Crossref
Melody K. Morris, Zachary Shriver, Ram Sasisekharan & Douglas A. Lauffenburger. (2012) Querying quantitative logic models (Q2LM) to study intracellular signaling networks and cell-cytokine interactions. Biotechnology Journal 7:3, pages 374-386.
Crossref
Crossref
Bing-Bing Yang, Michael A. Savin & Michael Green. (2012) Prevention of Chemotherapy-Induced Neutropenia with Pegfilgrastim: Pharmacokinetics and Patient Outcomes. Chemotherapy 58:5, pages 387-398.
Crossref
Crossref
Lorin K. Roskos. 2012. Twenty Years of G-CSF. Twenty Years of G-CSF
41
60
.
Pellegrino Musto. 2012. Twenty Years of G-CSF. Twenty Years of G-CSF
211
223
.
Bing-Bing Yang & Anna Kido. (2011) Pharmacokinetics and Pharmacodynamics of Pegfilgrastim. Clinical Pharmacokinetics 50:5, pages 295-306.
Crossref
Crossref
T. V. Andreeva, A. V. Artamonov, A. A. Bekarev, E. I. Vereschagin, P. G. Madonov, O. V. Pershina, E. G. Skurikhin, E. S. Khmelevskaya & A. M. Dygai. (2011) Role of Stromal and Thy 1,2+ Cells in the Mechanisms of Action of Immobilized Granulocyte Colony-Stimulating Factor during Cytostatic-Induced Myelosuppression. Bulletin of Experimental Biology and Medicine 150:5, pages 594-598.
Crossref
Crossref
Diane R. Mould. 2011. Pharmacokinetics in Drug Development. Pharmacokinetics in Drug Development
57
90
.
Lorin K. Roskos, Song Ren & Gabriel Robbie. 2011. Clinical Trial Simulations. Clinical Trial Simulations
361
396
.
Azzurra Romeo, Anna Chierichini, Alessandra Spagnoli, Mariangela Vittori, Michele Vacca, Maria Gozzer, Antonio Spadea, Barbara Anaclerico, Maria Laura Dessanti, Mariella D'Andrea, Giuseppe Toglia, Luciana Annino, Maria Concetta Petti, Andrea Mengarelli & William Arcese. (2010) Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization. Transfusion 50:11, pages 2432-2446.
Crossref
Crossref
Cornelius F. Waller, Miguel Bronchud, Stuart Mair & Rodeina Challand. (2010) Comparison of the pharmacodynamic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trial. Annals of Hematology 89:10, pages 971-978.
Crossref
Crossref
A. M. Dygai, E. G. Skurikhin, T. V. Andreeva, P. G. Madonov, E. I. Vereshagin, D. N. Kinsht, O. V. Pershina & E. S. Khmelevskaya. (2010) Effect of Immobilized Granulocyte Colony-Stimulating Factor on Hemopoietic Precursors of Various Classes during Cytostatic-Induced Myelosuppression. Bulletin of Experimental Biology and Medicine 149:3, pages 284-288.
Crossref
Crossref
R Ria, T Gasparre, G Mangialardi, A Bruno, G Iodice, A Vacca & F Dammacco. (2009) Comparison between filgrastim and lenograstim plus chemotherapy for mobilization of PBPCs. Bone Marrow Transplantation 45:2, pages 277-281.
Crossref
Crossref
M. Scholz, C. Engel, D. Apt, S. L. Sankar, E. Goldstein & M. Loeffler. (2009) Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony-stimulating factor derivative Maxy-G34 and pegfilgrastim in rats. Cell Proliferation 42:6, pages 823-837.
Crossref
Crossref
M. Scholz, M. Ackermann, C. Engel, F. Emmrich, M. Loeffler & M. Kamprad. (2009) A pharmacokinetic model of filgrastim and pegfilgrastim application in normal mice and those with cyclophosphamide-induced granulocytopaenia. Cell Proliferation 42:6, pages 813-822.
Crossref
Crossref
Gary H. Lyman, Anjana Lalla, Richard L. Barron & Robert W. Dubois. (2009) Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the united states. Clinical Therapeutics 31:5, pages 1092-1104.
Crossref
Crossref
M. Hofer, M. Pospíšil, J. Holá, A. Vacek, D. Štreitová & V. Znojil. (2008) Inhibition of Cyclooxygenase 2 in Mice Increases Production of G-CSF and Induces Radioprotection. Radiation Research 170:5, pages 566-571.
Crossref
Crossref
Bing‐Bing Yang, Anna Kido, Margaret Salfi, Suzanne Swan & John T. Sullivan. (2013) Pharmacokinetics and Pharmacodynamics of Pegfilgrastim in Subjects With Various Degrees of Renal Function. The Journal of Clinical Pharmacology 48:9, pages 1025-1031.
Crossref
Crossref
Maria Liljefors, Bo Nilsson, Håkan Mellstedt & Jan-Erik Frödin. (2007) Influence of varying doses of granulocyte-macrophage colony-stimulating factor on pharmacokinetics and antibody-dependent cellular cytotoxicity. Cancer Immunology, Immunotherapy 57:3, pages 379-388.
Crossref
Crossref
Alberto Ballestrero, Davide Boy, Roberta Gonella, Maurizio Miglino, Marino Clavio, Valentina Barbero, Alessio Nencioni, Marco Gobbi & Franco Patrone. (2007) Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas. Annals of Hematology 87:1, pages 49-55.
Crossref
Crossref
Bing‐Bing Yang, Anna Kido & Atsuko Shibata. (2012) Serum Pegfilgrastim Concentrations During Recovery of Absolute Neutrophil Count in Patients with Cancer Receiving Pegfilgrastim After Chemotherapy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27:10, pages 1387-1393.
Crossref
Crossref
Kazumi Komoriya, Yukio Kato, Yujiro Hayashi, Kazuhiro Ohsuye, Ryuichiro Nishigaki & Yuichi Sugiyama. (2007) Characterization of the Hepatic Disposition of Lanoteplase, a Rationally Designed Variant of Tissue Plasminogen Activator in Rodents. Drug Metabolism and Disposition 35:3, pages 469-475.
Crossref
Crossref
Gaëtan Vanstraelen, Pascale Frère, Marie-Christine Ngirabacu, Evelyne Willems, Georges Fillet & Yves Beguin. (2006) Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation. Experimental Hematology 34:3, pages 382-388.
Crossref
Crossref
Johannes C. Fischer, Markus Frick, Ralf Wassmuth, Alexander Platz, Michael Punzel & Peter Wernet. (2005) Superior mobilisation of haematopoietic progenitor cells with glycosylated G-CSF in male but not female unrelated stem cell donors. British Journal of Haematology 130:5, pages 740-746.
Crossref
Crossref
V. Vainstein, Y. Ginosar, M. Shoham, D.O. Ranmar, A. Ianovski & Z. Agur. (2005) The complex effect of granulocyte colony-stimulating factor on human granulopoiesis analyzed by a new physiologically-based mathematical model. Journal of Theoretical Biology 234:3, pages 311-327.
Crossref
Crossref
Francisco Hernández-Bernal, Idrian García-García, Carlos A. González-Delgado, Carmen Valenzuela-Silva, Ramón Soto-Hernández, Jorge Ducongé, Majel Cervantes-Llano, Elizabeth Blanco-Garcés, Víctor Rodríguez, Yanelda García-Vega, Iraldo Bello-Rivero, Lourdes Olivera-Ruano & Pedro López-Saura. (2005) Bioequivalence of two recombinant granulocyte colony-stimulating factor formulations in healthy male volunteers. Biopharmaceutics & Drug Disposition 26:4, pages 151-159.
Crossref
Crossref
Munetoshi SUGIURA, Yoshiyuki OHNO, Yasuhiko YAMADA, Hiroshi SUZUKI & Tatsuji IGA. (2004) Pharmacokinetic/Pharmacodynamic Analysis of Neutrophil Proliferation Induced by rhG-CSF in Patients Receiving Antineoplastic Drugs. YAKUGAKU ZASSHI 124:9, pages 599-604.
Crossref
Crossref
Nicolaus Kröger, Stefan Sonnenberg, Lourdes Cortes-Dericks, Petra Freiberger, Hanke Mollnau & Axel R. Zander. (2004) Kinetics of G-CSF and CD34+ cell mobilization after once or twice daily stimulation with rHu granulocyte-stimulating factor (lenograstim) in healthy volunteers: an intraindividual crossover study. Transfusion 44:1, pages 104-110.
Crossref
Crossref
Daan J.A. Crommelin, Gert Storm, Ruud Verrijk, Leo de Leede, Wim Jiskoot & Wim E. Hennink. (2003) Shifting paradigms: biopharmaceuticals versus low molecular weight drugs. International Journal of Pharmaceutics 266:1-2, pages 3-16.
Crossref
Crossref
Adam M Persky, Gayle A Brazeau & G??nther Hochhaus. (2003) Pharmacokinetics of the Dietary Supplement Creatine. Clinical Pharmacokinetics 42:6, pages 557-574.
Crossref
Crossref
Thomas Hartung, Sonja von Aulock, Christian Schneider & Eugen Faist. (2003) How to leverage an endogenous immune defense mechanism: The example of granulocyte colony-stimulating factor. Critical Care Medicine 31:Supplement, pages S65-S75.
Crossref
Crossref
Zenaide Quezado, Chantal Parent, Waheedullah Karzai, Michael Depietro, Charles Natanson, William Hammond, Robert L. Danner, Xizhong Cui, Yvonne Fitz, Steven M. Banks, Eric Gerstenberger & Peter Q. Eichacker. (2001)
Acute G-CSF therapy is not protective during lethal
E. coli
sepsis
. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 281:4, pages R1177-R1185.
Crossref
Crossref
Masaaki Fukuda, Mikio Oka, Yoshimasa Ishida, Haruki Kinoshita, Kenji Terashi, Minoru Fukuda, Shigeru Kawabata, Akitoshi Kinoshita, Hiroshi Soda & Shigeru Kohno. (2001) Effects of Renal Function on Pharmacokinetics of Recombinant Human Granulocyte Colony-Stimulating Factor in Lung Cancer Patients. Antimicrobial Agents and Chemotherapy 45:7, pages 1947-1951.
Crossref
Crossref
S Akizuki, F Mizorogi, T Inoue, K Sudo & A Ohnishi. (2000) Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects. Bone Marrow Transplantation 26:9, pages 939-946.
Crossref
Crossref
Darlene A. Calhoun & Robert D. Christensen. (2000) HUMAN DEVELOPMENTAL BIOLOGY OF GRANULOCYTE COLONY-STIMULATING FACTOR. Clinics in Perinatology 27:3, pages 559-576.
Crossref
Crossref
Darlene A. CalhounMathilde LunøeYan DuAlan D. HutsonMark VeermanRobert D. Christensen. (2000) Granulocyte Colony-Stimulating Factor Serum and Urine Concentrations in Neutropenic Neonates Before and After Intravenous Administration of Recombinant Granulocyte Colony-Stimulating Factor. Pediatrics 105:2, pages 392-397.
Crossref
Crossref
Luigi Rotondaro, Enrico De Paolis, Dario Ferrero, Laura D’Alatri, Giuseppe Raucci, Armando Fabbri, Gerrit J. Gerwig, Johannis P. Kamerling, Maurizio F. Mariani, Antonio Mele & Rita De Santis. (1999) Purification and characterization of two recombinant human granulocyte colony-stimulating factor glycoforms. Molecular Biotechnology 11:2, pages 117-128.
Crossref
Crossref
Sharon Bowen, Nadine Tare, Tomoaki Inoue, Motoo Yamasaki, Masami Okabe, Ikuo Horii & James F Eliason. (1999) Relationship between molecular mass and duration of activity of polyethylene glycol conjugated granulocyte colony-stimulating factor mutein. Experimental Hematology 27:3, pages 425-432.
Crossref
Crossref
Karen Li, Annie Wong, Chi Kong Li, Matthew Ming Kong Shing, Ki Wai Chik, Kam Sze Tsang, Howard Lai, Ting Fan Leung & Patrick Man Pan Yuen. (1999) Granulocyte colony–stimulating factor–mobilized peripheral blood stem cells in β-thalassemia patients. Experimental Hematology 27:3, pages 526-532.
Crossref
Crossref
Yiqing Feng & John McKearn. 1999. Clinical Applications of Cytokines and Growth Factors. Clinical Applications of Cytokines and Growth Factors
90
116
.